- July 26, 2021
- Posted by: Stratford Team
- Category: Business
Dr Alan E. Walts joins Hemogenyx Pharmaceuticals team; renowned business leader brings industry experience in corporate and private venture capital, business development, R&D and general management.
LONDON, UK / ACCESSWIRE / July 26, 2021 / Hemogenyx Pharmaceuticals plc (LSE:HEMO), the biopharmaceutical group developing new therapies and treatments for blood diseases, announces the appointment of Dr Alan E. Walts as a Board observer and business advisor.
Dr Walts is a US-based Venture Partner with Advent Life Sciences, a position he has held since January 2014. Dr Walts currently serves as a Director and audit committee member at Eloxx Pharmaceuticals (NASDAQ: ELOX), and as Executive Chairman of Artax Biopharma and PIC Therapeutics. He is also a founder, Director and Treasurer of The Termeer Foundation, a public 501(c)(3) organization founded in 2019. Dr Walts is currently an independent Director of Neuroelectrics Corp, and a business advisor and board…
